Publication | Closed Access
Inhalable Lactoferrin–Chondroitin Nanocomposites for Combined Delivery of Doxorubicin and Ellagic Acid to Lung Carcinoma
86
Citations
40
References
2018
Year
Overall, inhalable lactoferrin-chondroitin sulfate nanocomposites would be a promising carrier for targeted drug delivery to lung cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1